Ascendis Pharma A/S
ASNDLatest QuantConomy context for ASND: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Ascendis Pharma A/S
QuantConomy has a structured record for ASND. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ASND
- Name
- Ascendis Pharma A/S
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq tsx
Recent signals for ASND
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| volume spike | neutral | 39 | Jul 10, 08:00 PM | ASND volume spike: 329% of expected volume for Friday 20:00 UTC, price flat 0.03% (strength 39) |
| downtrend | bearish | 48 | Jul 10, 04:00 PM | ASND downtrend (drop): price -2.39% (strength 48, current 268.85) |
| major spike | neutral | 56 | Jul 9, 08:00 PM | ASND major volume spike: 564% of expected volume for Thursday 20:00 UTC, price flat 0.04% (strength 56) |
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ASND | NASDAQ | alpaca | Ascendis Pharma A/S American Depositary Shares |
| ASND | NASDAQ | alphavantage | Ascendis Pharma A/S |
| ASND | NASDAQ | fmp | Ascendis Pharma A/S |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | purchase | 100 | $219.00 | $21,900 | 4 on EDGAR |
| May 29, 2026 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | purchase | 250 | $223.32 | $55,830 | 4 on EDGAR |
| May 29, 2026 | BIENAIME JEAN JACQUES | Director | purchase | 200 | $223.76 | $44,752 | 4 on EDGAR |
| May 26, 2026 | BIENAIME JEAN JACQUES | Director | purchase | 200 | $236.24 | $47,247 | 4 on EDGAR |
| May 11, 2026 | JENSEN FLEMMING STEEN | See Remarks | sale | 19,460 | $238.49 | $4,641,021 | 4 on EDGAR |
| — | BIENAIME JEAN JACQUES | Director | — | — | — | — | 3 on EDGAR |
| — | HOLTUG LARS | Director | — | — | — | — | 3 on EDGAR |
| — | Morrison Lisa | Director | — | — | — | — | 3 on EDGAR |
| — | IMANI SIHAM | Director | — | — | — | — | 3 on EDGAR |
| — | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | — | — | — | — | 3 on EDGAR |
| — | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | — | — | — | — | 3 on EDGAR |
| — | SPROGOE KENNETT | See Remarks | — | — | — | — | 3 on EDGAR |
| — | PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG | EVP & Chief Admin Officer | — | — | — | — | 3 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ASND context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access